Skip to main content
. 2017 Aug 14;8(51):88622–88629. doi: 10.18632/oncotarget.20242

Table 4. Clinicopathologic information from breast cancer patients in the epidemiological study.

Clinicopathologic information Case no. (%)
Tumor Type
 IDC 496 (96.1)
 Others 20 (3.9)
Tumor Size (cm)
 Less than 2 = 210 (40.7)
 2 to 5 = 228 (44.2)
 More than 5 42 (8.1)
 Unknown 36 (7.0)
LN metastasis
 Positive 236 (45.7)
 Negative 279 (54.1)
 Unknown 1 (0.2)
ER
 Negative 192 (37.2)
 Positive 292 (56.6)
 Unknown 32 (6.2)
PR
 Negative 161 (31.2)
 Positive 323 (62.6)
 Unknown 32 (6.2)
CerbB-2
 Negative 303 (58.7)
 Positive 181 (35.1)
 Unknown 32 (6.2)
P53
 Negative 338 (65.5)
 Positive 142 (27.5)
 Unknown 36 (7.0)